Kalvista Pharmaceuticals Stock Volatility

KALV Stock  USD 11.07  0.04  0.36%   
Kalvista Pharmaceuticals has Sharpe Ratio of -0.0162, which conveys that the firm had a -0.0162% return per unit of risk over the last 3 months. Kalvista Pharmaceuticals exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kalvista Pharmaceuticals' Mean Deviation of 3.23, downside deviation of 3.97, and Risk Adjusted Performance of 0.0223 to check out the risk estimate we provide. Key indicators related to Kalvista Pharmaceuticals' volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
Kalvista Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Kalvista daily returns, and it is calculated using variance and standard deviation. We also use Kalvista's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Kalvista Pharmaceuticals volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Kalvista Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Kalvista Pharmaceuticals at lower prices. For example, an investor can purchase Kalvista stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Kalvista Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving against Kalvista Stock

  0.62SNDL SNDL Inc Buyout TrendPairCorr
  0.54CVS CVS Health Corp Financial Report 1st of May 2024 PairCorr
  0.53YS YS Biopharma Report 22nd of April 2024 PairCorr
  0.52PFE Pfizer Inc Fiscal Quarter End 31st of March 2024 PairCorr
  0.52CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.5DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.46MESO Mesoblast TrendingPairCorr
  0.41MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.41VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr

Kalvista Pharmaceuticals Market Sensitivity And Downside Risk

Kalvista Pharmaceuticals' beta coefficient measures the volatility of Kalvista stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Kalvista stock's returns against your selected market. In other words, Kalvista Pharmaceuticals's beta of -0.95 provides an investor with an approximation of how much risk Kalvista Pharmaceuticals stock can potentially add to one of your existing portfolios. Kalvista Pharmaceuticals shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kalvista Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kalvista Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Kalvista Pharmaceuticals Demand Trend
Check current 90 days Kalvista Pharmaceuticals correlation with market (NYSE Composite)

Kalvista Beta

    
  -0.95  
Kalvista standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.41  
It is essential to understand the difference between upside risk (as represented by Kalvista Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Kalvista Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in kalvista stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Kalvista Pharmaceuticals.

Using Kalvista Put Option to Manage Risk

Put options written on Kalvista Pharmaceuticals grant holders of the option the right to sell a specified amount of Kalvista Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Kalvista Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Kalvista Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Kalvista Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.

Kalvista Pharmaceuticals' PUT expiring on 2024-04-19

   Profit   
       Kalvista Pharmaceuticals Price At Expiration  

Current Kalvista Pharmaceuticals Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2024-04-19 PUT at $12.5-0.73730.177751692024-04-191.25 - 2.10.83View
Put
2024-04-19 PUT at $10.0-0.2440.16511662024-04-190.2 - 0.40.3View
View All Kalvista Pharmaceuticals Options

Kalvista Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Kalvista Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Kalvista Pharmaceuticals' price changes. Investors will then calculate the volatility of Kalvista Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Kalvista Pharmaceuticals' volatility:

Historical Volatility

This type of stock volatility measures Kalvista Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Kalvista Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Kalvista Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Kalvista Pharmaceuticals' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Kalvista Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Kalvista Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Kalvista Pharmaceuticals has a beta of -0.9521 . This indicates
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kalvista Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kalvista Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kalvista stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Kalvista Pharmaceuticals has an alpha of 0.2129, implying that it can generate a 0.21 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Kalvista Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how kalvista stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Kalvista Pharmaceuticals Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Kalvista Pharmaceuticals Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Kalvista Pharmaceuticals is -6188.27. The daily returns are distributed with a variance of 19.46 and standard deviation of 4.41. The mean deviation of Kalvista Pharmaceuticals is currently at 3.3. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.56
α
Alpha over NYSE Composite
0.21
β
Beta against NYSE Composite-0.95
σ
Overall volatility
4.41
Ir
Information ratio -0.0069

Kalvista Pharmaceuticals Stock Return Volatility

Kalvista Pharmaceuticals historical daily return volatility represents how much of Kalvista Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The venture inherits 4.4117% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.5731% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Kalvista Pharmaceuticals Volatility

Volatility is a rate at which the price of Kalvista Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Kalvista Pharmaceuticals may increase or decrease. In other words, similar to Kalvista's beta indicator, it measures the risk of Kalvista Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Kalvista Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks KVD824, an oral product candidate for the treatment of HAE and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. Kalvista Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.
Kalvista Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Kalvista Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Kalvista Pharmaceuticals' price varies over time.

3 ways to utilize Kalvista Pharmaceuticals' volatility to invest better

Higher Kalvista Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Kalvista Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Kalvista Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Kalvista Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Kalvista Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Kalvista Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Kalvista Pharmaceuticals Investment Opportunity

Kalvista Pharmaceuticals has a volatility of 4.41 and is 7.74 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Kalvista Pharmaceuticals is lower than 38 percent of all global equities and portfolios over the last 90 days. You can use Kalvista Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend and little activity. Check odds of Kalvista Pharmaceuticals to be traded at $10.96 in 90 days.

Good diversification

The correlation between Kalvista Pharmaceuticals and NYA is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.

Kalvista Pharmaceuticals Additional Risk Indicators

The analysis of Kalvista Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Kalvista Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Kalvista Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Kalvista Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Kalvista Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Kalvista Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Kalvista Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Kalvista Pharmaceuticals.
When determining whether Kalvista Pharmaceuticals is a strong investment it is important to analyze Kalvista Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kalvista Pharmaceuticals' future performance. For an informed investment choice regarding Kalvista Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Kalvista Stock analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Kalvista Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kalvista Pharmaceuticals. If investors know Kalvista will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kalvista Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.12)
Revenue Per Share
0.214
Quarterly Revenue Growth
0.307
Return On Assets
(0.42)
Return On Equity
(0.79)
The market value of Kalvista Pharmaceuticals is measured differently than its book value, which is the value of Kalvista that is recorded on the company's balance sheet. Investors also form their own opinion of Kalvista Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kalvista Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kalvista Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kalvista Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kalvista Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kalvista Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kalvista Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.